From ATS 2010
Monitoring Exhaled Nitric Oxide (FENO) to Tailor the Lowest Effective Dose of Oral Corticosteroids in Sever Asthma (MONOSA- Study)
ERJ (June 2010) editorial: An eye to the future: exhaled nitric oxide as a predictor of clinical outcomes in asthma
FENO as a Marker of Airways Inflammation: The Possible Implications in Childhood Asthma Management
Diagnosing asthma in general practice
More information: